The role of insulin-like growth factors in prostate biology

Journal of Andrology

Volumn 17, Issue 1, 1996, Pages 2-4

  Peehl, Donna M ^a   Cohen, Pinchas ^b   Rosenfeld, Ron G ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN RECEPTOR;

ANTIGEN EXPRESSION; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MITOGENESIS; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; SHORT SURVEY; STROMA CELL;

ANIMALS; CELLS, CULTURED; HUMANS; MALE; PROSTATE; SOMATOMEDINS;

EID: 0030000740     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (14)

1. Birnbaum RS, Ware JL, Plymate SR. Insulin-like growth factor-binding protein-3 expression and secretion by cultures of human prostate epithelial cells and stromal fibroblasts. J Endocrinol 1994;141:535-540.
2. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 1992;75:1046-1053.
3. Cohen P, Peehl DM, Baker B, Liu F, Hintz RL, Rosenfeld RG. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia. J Clin Endocrinol Melab 1994a;79:1410-1415.
4. Cohen P, Peehl DM, Graves HCB, Rosenfeld RG. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol 1994b;142:407-415.
5. Cohen P, Peehl DM, Lamson G, Rosenfeld RG. Insulin-like growth factors (IGFs), IGF receptors and IGF binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab 1991; 73:401-407.
6. Cohen P, Peehl DM, Stamey TA, Wilson KF, Clemmons DR, Rosenfeld RG. Elevated levels of insulin-like growth factor binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab 1993;76:1031-1035.
7. Cohick WS, Clemmons DR. The insulin-like growth factors. Annu Rev Physiol 1993;55:131-153.
8. Iwamura M, Sluss PM, Casamento JB, Cockett ATK. Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate 1993;22:243-252.
9. Kanety H, Madjar Y, Pagan Y, Levi J, Papa MZ, Pariente C, Goldwasser B, Karasik A. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J Clin Endocrinol Metab 1993;77:229-233.
10. McNeal JE. Pathology of benign prostatic hyperplasia: insight into etiology. J Urol Clin N Am 1990;17:477-486.
11. Oh Y, Müller HL, Lamson G, Rosenfeld RG. Insulin-like growth factor (IGF)- independent action of IGF- binding protein-3 in Hs578T human breast cancer cells. J Biol Chem 1993a;268:14964-14971.
12. Oh Y, Müller HL, Pham H, Rosenfeld RG. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 1993b;268:26045-26048.
13. Peehl DM, Cohen P, Rosenfeld RG. The insulin-like growth factor system in the prostate. World J Urol 1995; in press.
14. Pietrzkowski Z, Mulholland G, Gomella L, Jameson BA, Wernicke D, Baserga R. Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor I. Cancer Res 1993;53: 1102-1106.